Elanco Animal Health Incorporated (ELAN) Q3 Earnings and Revenues Surpass Estimates
Elanco Animal Health Incorporated (ELAN) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.13 per share a year ago.
Elanco Animal Health Incorporated (ELAN) Reports Next Week: What You Should Expect
Elanco Animal Health (ELAN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Elanco Animal Health Obtains FDA Authorization for Screwworm Treatment
Health and Human Services Secretary Robert F. Kennedy Jr. determined that New World screwworm presents significant potential for a public health emergency.
Elanco Animal Health Incorporated (ELAN) is a Great Momentum Stock: Should You Buy?
Does Elanco Animal Health Incorporated (ELAN) have what it takes to be a top stock pick for momentum investors? Let's find out.
Elanco Animal Health (ELAN) Upgraded to Buy: What Does It Mean for the Stock?
Elanco Animal Health (ELAN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Elanco Animal Health Incorporated (ELAN) Q2 2025 Earnings Call Transcript
Elanco Animal Health Incorporated (NYSE:ELAN ) Q2 2025 Earnings Conference Call August 7, 2025 9:00 AM ET Company Participants Jeffrey N. Simmons - President, CEO & Director Robert M.
Elanco Animal Health Q2: Rising Innovation Revenue, Initiate At Buy
I rate Elanco Animal Health Incorporated shares a Buy with a $20 fair value, driven by strong innovation and recent operational improvements. Elanco's focus on innovative products like Zenrelia and strategic divestitures positions it for growth in both companion and farm animal markets. Strong Q2 results, raised full-year guidance, and increased innovation revenue targets support my positive outlook for future growth.
Elanco Animal Health (ELAN) Reports Q2 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Elanco Animal Health (ELAN) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Elanco Animal Health Incorporated (ELAN) Q2 Earnings and Revenues Beat Estimates
Elanco Animal Health Incorporated (ELAN) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.3 per share a year ago.
Curious about Elanco Animal Health (ELAN) Q2 Performance? Explore Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Elanco Animal Health (ELAN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
ELAN vs. USPH: Which Stock Is the Better Value Option?
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Elanco Animal Health Incorporated (ELAN) and U.S. Physical Therapy (USPH). But which of these two stocks offers value investors a better bang for their buck right now?
What Makes Elanco Animal Health (ELAN) a New Buy Stock
Elanco Animal Health (ELAN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
